Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award Chief Executive Officer acquired 872,769 shares (grant or award)
  2. 4 Grant or award Chief Medical Officer, EVP R&D acquired 1,161,938 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes Former President and CEO gave up 14,250 shares (to pay taxes)
  8. 4 Shares withheld for taxes SVP and CFO gave up 8,548 shares (to pay taxes)
  9. 4 Shares withheld for taxes Former SVP, Gen. Counsel gave up 8,550 shares (to pay taxes)
  10. 4 Grant or award Director acquired 17,857 shares (grant or award)
  11. 4 Open-market sale Director sold 600,000 shares at an average $0.35 ($207,720)
  12. 4 Open-market sale Director sold 745,892 shares at an average $0.38 ($285,125)
  13. 4 Open-market sale Director sold 1,523,346 shares at an average $0.37 ($570,155)
  14. 4 Open-market sale Director sold 1,430,753 shares at an average $0.43 ($609,169)
  15. 4 Open-market sale Director sold 3,078,820 shares at an average $0.48 ($1,474,249)
  16. 4 Open-market sale Director sold 1,173,582 shares at an average $0.44 ($515,106)
  17. 4 Open-market sale Director sold 1,513,088 shares at an average $0.49 ($734,189)
  18. 4 Open-market sale Director sold 100,000 shares at $0.41 ($41,400)
  19. 4 Open-market sale Director sold 1,223,936 shares at an average $0.43 ($521,987)
  20. 4/A Open-market sale Director sold 188,322 shares at $0.55 ($103,050)

Page 15 of 29 · 564 filings